Everest Medicines' Partner Calliditas Therapeutics Announces U.S. FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon®
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameEverest Medicines Ltd
-
Registration countryCayman Islands
-
IndustryMiscellaneous Healthcare: Products and Services
-
М/S&P/F
*** /*** /***









